Nutex Health (NUTX) Capital Leases (2021 - 2026)

Nutex Health (NUTX) has 6 years of Capital Leases data on file, last reported at $268.8 million in Q1 2026.

• Quarterly Capital Leases rose 4.02% year-over-year to $268.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268.8 million (up 4.02% YoY) and the FY2025 annual result came in at $268.9 million, up 3.62% from the prior year.
• Capital Leases was little changed at $268.8 million in Q1 2026 per NUTX's latest filing, from $268.9 million in the prior quarter.
• The five-year high for Capital Leases was $270.1 million in Q3 2025, with the low at $192.5 million in Q2 2022.
• Average Capital Leases over 5 years is $236.5 million, with a median of $233.9 million recorded in 2024.
• Year-over-year, Capital Leases surged 209.76% in 2022 and declined 8.67% in 2024.
• Nutex Health's Capital Leases stood at $203.6 million in 2022, then rose by 5.04% to $213.9 million in 2023, then increased by 21.32% to $259.5 million in 2024, then climbed by 3.62% to $268.9 million in 2025, then decreased by 0.04% to $268.8 million in 2026.
• Business Quant data shows NUTX's Capital Leases at $268.8 million in Q1 2026, $268.9 million in Q4 2025, and $270.1 million in Q3 2025.